|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Emotion - The New Brand Integrator
Author(s)Gil Bashe
Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
Advertisement
Articles in this issue
about 25 years ago
Industry Under Investigationabout 25 years ago
Emotion - The New Brand Integratorabout 25 years ago
For Love of the Gameabout 25 years ago
Field of Dreamsabout 25 years ago
Workshop: Access Optionsabout 25 years ago
Rx-to-OTC: Unwanted Attentionabout 25 years ago
Emotion - Biotech Renaissance Manabout 25 years ago
Relocation: Coming to Americaabout 25 years ago
Stocks: Catching the Market Bluesabout 25 years ago
Gathering LightAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5